Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05800756
Status:
RECRUITING
Last Update Posted:
2023-04-06
First Post:
2023-03-23
Brief Title:
Pyrotinib Combined With TrastuzumabDalpiciclib and Letrozole for HRHER2 Breast Cancer
Sponsor:
Yantai Yuhuangding Hospital
Organization:
Yantai Yuhuangding Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| breast cancer CDK46 inhibitor hormone receptor-positive HER2 positive dalpiciclib pyrotinib | View |